|
|
Article: A misunderstood miracle. (analysis of therapeutic drawbacks of Redux)
- Article from:
- Newsletter-People's Medical Society
- Article date:
- April 1, 1997
CopyrightCOPYRIGHT 1997 People's Medical Society, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
When marketers of the drug Redux (dexfenfluramine) introduced their new product one year ago as "an important milestone in America's war on fat," America's dieters breathed a collective sigh of relief at the solution to their problems. No more fat-free ice cream, no more sit-ups, no more "Sweatin' to the Oldies" with Richard Simmons. There was much rejoicing.
And not just because America thought it would look better in a swimsuit. Obesity -- defined as a weight of 20 percent or more above one's Ideal body weight -- is the second leading cause of preventable death in the United States. A major risk factor for heart disease, diabetes and some cancers, obesity ...